+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson's Disease Patients

Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson's Disease Patients

Frontiers in Neurology 6: 263

Extracampine hallucinations (EH), the sense of a presence or fleeting movement in the absence of an associated visual percept, have been reported in Parkinson's disease (PD) patients but their prevalence, characteristics, and temporal relationship to visual hallucinations (VH) remain unclear. Given that, VH are predictive of cognitive impairment in PD, improved understanding of EH may have significant prognostic implications. The objective of this study is to evaluate the prevalence and characteristics of EH in a large unselected population with PD and to assess the temporal relationship between EH, VH, and memory decline. Cross-sectional data were collected from 414 PD patients using a questionnaire circulated via an online patient community. Data were obtained regarding the occurrence, timing, and characteristics of VH and EH and symptoms of PD, disease duration, disease severity, and medication history. About 50.4% of respondents reported EH and 15.5% reported VH. EH were typically experienced alongside, rather than behind, the individual (p < 0.001) without clear lateralization (p = 0.438) and were more likely to be of unfamiliar presences (p < 0.001). The occurrence of EH was associated with Hoehn and Yahr score (p = 0.002) but not disease duration (p = 0.158). EH onset was associated with VH onset (p = 0.046) and occurred after the onset of anosmia (p < 0.001), cognitive decline (p = 0.002), and sleep disturbance (p = 0.002). The reported prevalence of EH in PD patients was threefold greater than that of VH, with similar timings of onset, suggesting that EH are under-recognized and under-reported. Further work is needed to determine whether EH are predictive of cognitive decline.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057876529

Download citation: RISBibTeXText

PMID: 26733937

DOI: 10.3389/fneur.2015.00263

Related references

Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson's disease. Journal of the Neurological Sciences 372: 471-476, 2016

Extracampine hallucinations. Lancet 361(9367): 1479-1480, 2003

Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. International Journal of Geriatric Psychiatry 28(6): 626-631, 2014

"-but who is that on the other side of you?" Extracampine hallucinations revisited. Lancet 360(9350): 2064-2066, 2002

Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 83(10): 1019-1021, 2012

Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease. Journal of Parkinson's Disease 2(3): 199-205, 2014

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123: 733-745, 2000

A comparison of montreal cognitive assessment between patients with visual hallucinations and without visual hallucinations in Parkinson's disease. Clinical Neurology and Neurosurgery 130: 98-100, 2015

Hallucinations in Parkinson's disease. prevalence, phenomenology and risk factors. Fenelon G* mahieux F, huon R, Ziegler M. Brain 2000;123:733-745. American Journal of Ophthalmology 130(2): 261-262, 2000

Hallucinations in Parkinson's disease--a study of forty three patients. Journal of the Association of Physicians of India 52: 703-706, 2005

Cognitive changes in Parkinson's disease patients with visual hallucinations. Dementia and Geriatric Cognitive Disorders 23(5): 281-288, 2007

A study of visual hallucinations in patients with Parkinson's disease. Journal of Neurology 244(6): 371-377, 1997

Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. American Journal of Critical Care 7(3): 240-244, 1998

Neuropsychological deficits in Parkinson's disease patients with visual hallucinations. Movement Disorders 21(9): 1483-1487, 2006